Rosuvastatin reduces rat intestinal ischemia-reperfusion injury associated with the preservation of endothelial nitric oxide synthase protein

AIM: To investigate the protective effect of rosuvastatin on ischemia-reperfusion (I-R)-induced small intestinal injury and inflammation in rats, and to determine the effect of this agent on the expression of endothelial nitric oxide synthase (eNOS) protein. METHODS: Intestinal damage was induced in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:World journal of gastroenterology : WJG 2006-04, Vol.12 (13), p.2024-2030
Hauptverfasser: Naito, Yuji, Katada, Kazuhiro, Takagi, Tomohisa, Tsuboi, Hisato, Kuroda, Masaaki, Handa, Osamu, Kokura, Satoshi, Yoshida, Norimasa, Ichikawa, Hiroshi, Yoshikawa, Toshikazu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2030
container_issue 13
container_start_page 2024
container_title World journal of gastroenterology : WJG
container_volume 12
creator Naito, Yuji
Katada, Kazuhiro
Takagi, Tomohisa
Tsuboi, Hisato
Kuroda, Masaaki
Handa, Osamu
Kokura, Satoshi
Yoshida, Norimasa
Ichikawa, Hiroshi
Yoshikawa, Toshikazu
description AIM: To investigate the protective effect of rosuvastatin on ischemia-reperfusion (I-R)-induced small intestinal injury and inflammation in rats, and to determine the effect of this agent on the expression of endothelial nitric oxide synthase (eNOS) protein. METHODS: Intestinal damage was induced in male Sprague-Dawley rats by clamping both the superior mesenteric artery and the celiac trunk for 30 min, followed by reperfusion for 60 min. Rosuvastatin dissolved in physiological saline was administered intraperitoneally 60 min before ischemia. The severity of the intestinal mucosal injury and inflammation were evaluated by several biochemical markers, as well as by histological findings. The protein levels of eNOS were determined by Western blot. RESULTS: The levels of both intraluminal hemoglobin and protein, as indices of mucosal damage, were significantly increased in the I-R group compared with those in the sham-operated group. These increases, however, were significantly inhibited by treatment with rosuvastatin in a dose-dependent manner. The protective effects of rosuvastatin were also confirmed by histological findings. Exposure of the small intestine to I-R resulted in mucosal inflammation characterized by significant increases in thiobarbituric acid-reactive substances, tissueassociated myeloperoxidase activity, and the mucosal contents of rat cytokine-induced neutrophil chemoattracrant-1 (CINC-1) and tumor necrosis factor-α(TNF-α). These increases in inflammatory parameters after I-R were significantly inhibited by pretreatment with rosuvo astatin at a dose of 10 mg/kg. Furthermore, mRNA expression of CINC-1 and TNF-α was increased after I-R, and this increase was also inhibited by rosuvastatin. The mucosal protein levels of eNOS decreased during I-R, but were preserved in rats treated with rosuvastatin. CONCLUSION: Rosuvastatin inhibits rat intestinal injury and inflammation induced by I-R, and its protection is associated with the preservation of eNOS protein.
doi_str_mv 10.3748/wjg.v12.i13.2024
format Article
fullrecord <record><control><sourceid>wanfang_jour_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4087679</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>21773589</cqvip_id><wanfj_id>wjg200613007</wanfj_id><sourcerecordid>wjg200613007</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-c66644939aefba29dd2fe212310af0fa6d86daea8adf1e70f475b5793c3a47353</originalsourceid><addsrcrecordid>eNpVkV2rEzEQhoMonlq990qCiHdb87XZ3RtBDn7BAUH0Okx3J93UbdKTZFv7I_zPprT4cRWYeefJzPsS8pyzlWxU--a43awOXKwclyvBhHpAFkLwrhKtYg_JgjPWVJ0UzQ15ktKWMSFlLR6TG6516dV8QX59DWk-QMqQnacRh7nHRCNk6nzGVIowUZf6EXcOqoh7jHZOLvjS387xRCGl0DvIONCjyyPNI9J9xITxUJBFFyxFP4RSn1xheZej62n46Qak6eTzCOk8ETI6_5Q8sjAlfHZ9l-T7h_ffbj9Vd18-fr59d1f1qma56rXWSnWyA7RrEN0wCIuCC8kZWGZBD60eAKGFwXJsmFVNva6bTvYSVCNruSRvL9z9vN7h0KPPESazj24H8WQCOPN_x7vRbMLBKNY2uoCW5NUFcARvwW_MNsyxWJVMiUQwprks3hfZ6-s_MdzPxU6zK17iNIHHMCejm7buhFJFyC7CPoaUIto_u3BmzlGfuaZEbUrU5hx1GXnx7w1_B67ZFsHLK3MMfnPvypZr6H9YN6ERvCk-tJ38DSGUt3Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67859244</pqid></control><display><type>article</type><title>Rosuvastatin reduces rat intestinal ischemia-reperfusion injury associated with the preservation of endothelial nitric oxide synthase protein</title><source>MEDLINE</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Naito, Yuji ; Katada, Kazuhiro ; Takagi, Tomohisa ; Tsuboi, Hisato ; Kuroda, Masaaki ; Handa, Osamu ; Kokura, Satoshi ; Yoshida, Norimasa ; Ichikawa, Hiroshi ; Yoshikawa, Toshikazu</creator><creatorcontrib>Naito, Yuji ; Katada, Kazuhiro ; Takagi, Tomohisa ; Tsuboi, Hisato ; Kuroda, Masaaki ; Handa, Osamu ; Kokura, Satoshi ; Yoshida, Norimasa ; Ichikawa, Hiroshi ; Yoshikawa, Toshikazu</creatorcontrib><description>AIM: To investigate the protective effect of rosuvastatin on ischemia-reperfusion (I-R)-induced small intestinal injury and inflammation in rats, and to determine the effect of this agent on the expression of endothelial nitric oxide synthase (eNOS) protein. METHODS: Intestinal damage was induced in male Sprague-Dawley rats by clamping both the superior mesenteric artery and the celiac trunk for 30 min, followed by reperfusion for 60 min. Rosuvastatin dissolved in physiological saline was administered intraperitoneally 60 min before ischemia. The severity of the intestinal mucosal injury and inflammation were evaluated by several biochemical markers, as well as by histological findings. The protein levels of eNOS were determined by Western blot. RESULTS: The levels of both intraluminal hemoglobin and protein, as indices of mucosal damage, were significantly increased in the I-R group compared with those in the sham-operated group. These increases, however, were significantly inhibited by treatment with rosuvastatin in a dose-dependent manner. The protective effects of rosuvastatin were also confirmed by histological findings. Exposure of the small intestine to I-R resulted in mucosal inflammation characterized by significant increases in thiobarbituric acid-reactive substances, tissueassociated myeloperoxidase activity, and the mucosal contents of rat cytokine-induced neutrophil chemoattracrant-1 (CINC-1) and tumor necrosis factor-α(TNF-α). These increases in inflammatory parameters after I-R were significantly inhibited by pretreatment with rosuvo astatin at a dose of 10 mg/kg. Furthermore, mRNA expression of CINC-1 and TNF-α was increased after I-R, and this increase was also inhibited by rosuvastatin. The mucosal protein levels of eNOS decreased during I-R, but were preserved in rats treated with rosuvastatin. CONCLUSION: Rosuvastatin inhibits rat intestinal injury and inflammation induced by I-R, and its protection is associated with the preservation of eNOS protein.</description><identifier>ISSN: 1007-9327</identifier><identifier>EISSN: 2219-2840</identifier><identifier>DOI: 10.3748/wjg.v12.i13.2024</identifier><identifier>PMID: 16610051</identifier><language>eng</language><publisher>United States: Department of Medical Proteomics, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan%Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine,Kyoto 602-8566, Japan%Department of Biomedical Safety Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan%Molecular Gastroenterology and Hepatology,Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan%Department of Food Sciences and Nutritional Health, The Faculty of Human Environment, Kyoto Prefectural University, Kyoto 606-8522, Japan%Department of Medical Proteomics, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan</publisher><subject>Animals ; Basic Research ; Chemokine CXCL1 ; Chemokines, CXC - genetics ; Fluorobenzenes - pharmacology ; Fluorobenzenes - therapeutic use ; Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology ; Intestines - blood supply ; Lipid Peroxidation - drug effects ; Male ; Nitric Oxide Synthase Type III - analysis ; Pyrimidines - pharmacology ; Pyrimidines - therapeutic use ; Rats ; Rats, Sprague-Dawley ; Reperfusion Injury - enzymology ; Reperfusion Injury - prevention &amp; control ; RNA, Messenger - analysis ; Rosuvastatin Calcium ; Sulfonamides - pharmacology ; Sulfonamides - therapeutic use ; Tumor Necrosis Factor-alpha - genetics ; 内皮氧化酶 ; 缺血再灌注损伤 ; 肠疾病 ; 蛋白基因</subject><ispartof>World journal of gastroenterology : WJG, 2006-04, Vol.12 (13), p.2024-2030</ispartof><rights>Copyright © Wanfang Data Co. Ltd. All Rights Reserved.</rights><rights>2006 Baishideng Publishing Group Co., Limited. All rights reserved. 2006</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c450t-c66644939aefba29dd2fe212310af0fa6d86daea8adf1e70f475b5793c3a47353</citedby><cites>FETCH-LOGICAL-c450t-c66644939aefba29dd2fe212310af0fa6d86daea8adf1e70f475b5793c3a47353</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/84123X/84123X.jpg</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4087679/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4087679/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,724,777,781,882,27905,27906,53772,53774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16610051$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Naito, Yuji</creatorcontrib><creatorcontrib>Katada, Kazuhiro</creatorcontrib><creatorcontrib>Takagi, Tomohisa</creatorcontrib><creatorcontrib>Tsuboi, Hisato</creatorcontrib><creatorcontrib>Kuroda, Masaaki</creatorcontrib><creatorcontrib>Handa, Osamu</creatorcontrib><creatorcontrib>Kokura, Satoshi</creatorcontrib><creatorcontrib>Yoshida, Norimasa</creatorcontrib><creatorcontrib>Ichikawa, Hiroshi</creatorcontrib><creatorcontrib>Yoshikawa, Toshikazu</creatorcontrib><title>Rosuvastatin reduces rat intestinal ischemia-reperfusion injury associated with the preservation of endothelial nitric oxide synthase protein</title><title>World journal of gastroenterology : WJG</title><addtitle>World Journal of Gastroenterology</addtitle><description>AIM: To investigate the protective effect of rosuvastatin on ischemia-reperfusion (I-R)-induced small intestinal injury and inflammation in rats, and to determine the effect of this agent on the expression of endothelial nitric oxide synthase (eNOS) protein. METHODS: Intestinal damage was induced in male Sprague-Dawley rats by clamping both the superior mesenteric artery and the celiac trunk for 30 min, followed by reperfusion for 60 min. Rosuvastatin dissolved in physiological saline was administered intraperitoneally 60 min before ischemia. The severity of the intestinal mucosal injury and inflammation were evaluated by several biochemical markers, as well as by histological findings. The protein levels of eNOS were determined by Western blot. RESULTS: The levels of both intraluminal hemoglobin and protein, as indices of mucosal damage, were significantly increased in the I-R group compared with those in the sham-operated group. These increases, however, were significantly inhibited by treatment with rosuvastatin in a dose-dependent manner. The protective effects of rosuvastatin were also confirmed by histological findings. Exposure of the small intestine to I-R resulted in mucosal inflammation characterized by significant increases in thiobarbituric acid-reactive substances, tissueassociated myeloperoxidase activity, and the mucosal contents of rat cytokine-induced neutrophil chemoattracrant-1 (CINC-1) and tumor necrosis factor-α(TNF-α). These increases in inflammatory parameters after I-R were significantly inhibited by pretreatment with rosuvo astatin at a dose of 10 mg/kg. Furthermore, mRNA expression of CINC-1 and TNF-α was increased after I-R, and this increase was also inhibited by rosuvastatin. The mucosal protein levels of eNOS decreased during I-R, but were preserved in rats treated with rosuvastatin. CONCLUSION: Rosuvastatin inhibits rat intestinal injury and inflammation induced by I-R, and its protection is associated with the preservation of eNOS protein.</description><subject>Animals</subject><subject>Basic Research</subject><subject>Chemokine CXCL1</subject><subject>Chemokines, CXC - genetics</subject><subject>Fluorobenzenes - pharmacology</subject><subject>Fluorobenzenes - therapeutic use</subject><subject>Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology</subject><subject>Intestines - blood supply</subject><subject>Lipid Peroxidation - drug effects</subject><subject>Male</subject><subject>Nitric Oxide Synthase Type III - analysis</subject><subject>Pyrimidines - pharmacology</subject><subject>Pyrimidines - therapeutic use</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Reperfusion Injury - enzymology</subject><subject>Reperfusion Injury - prevention &amp; control</subject><subject>RNA, Messenger - analysis</subject><subject>Rosuvastatin Calcium</subject><subject>Sulfonamides - pharmacology</subject><subject>Sulfonamides - therapeutic use</subject><subject>Tumor Necrosis Factor-alpha - genetics</subject><subject>内皮氧化酶</subject><subject>缺血再灌注损伤</subject><subject>肠疾病</subject><subject>蛋白基因</subject><issn>1007-9327</issn><issn>2219-2840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkV2rEzEQhoMonlq990qCiHdb87XZ3RtBDn7BAUH0Okx3J93UbdKTZFv7I_zPprT4cRWYeefJzPsS8pyzlWxU--a43awOXKwclyvBhHpAFkLwrhKtYg_JgjPWVJ0UzQ15ktKWMSFlLR6TG6516dV8QX59DWk-QMqQnacRh7nHRCNk6nzGVIowUZf6EXcOqoh7jHZOLvjS387xRCGl0DvIONCjyyPNI9J9xITxUJBFFyxFP4RSn1xheZej62n46Qak6eTzCOk8ETI6_5Q8sjAlfHZ9l-T7h_ffbj9Vd18-fr59d1f1qma56rXWSnWyA7RrEN0wCIuCC8kZWGZBD60eAKGFwXJsmFVNva6bTvYSVCNruSRvL9z9vN7h0KPPESazj24H8WQCOPN_x7vRbMLBKNY2uoCW5NUFcARvwW_MNsyxWJVMiUQwprks3hfZ6-s_MdzPxU6zK17iNIHHMCejm7buhFJFyC7CPoaUIto_u3BmzlGfuaZEbUrU5hx1GXnx7w1_B67ZFsHLK3MMfnPvypZr6H9YN6ERvCk-tJ38DSGUt3Q</recordid><startdate>20060407</startdate><enddate>20060407</enddate><creator>Naito, Yuji</creator><creator>Katada, Kazuhiro</creator><creator>Takagi, Tomohisa</creator><creator>Tsuboi, Hisato</creator><creator>Kuroda, Masaaki</creator><creator>Handa, Osamu</creator><creator>Kokura, Satoshi</creator><creator>Yoshida, Norimasa</creator><creator>Ichikawa, Hiroshi</creator><creator>Yoshikawa, Toshikazu</creator><general>Department of Medical Proteomics, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan%Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine,Kyoto 602-8566, Japan%Department of Biomedical Safety Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan%Molecular Gastroenterology and Hepatology,Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan%Department of Food Sciences and Nutritional Health, The Faculty of Human Environment, Kyoto Prefectural University, Kyoto 606-8522, Japan%Department of Medical Proteomics, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan</general><general>Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine,Kyoto 602-8566, Japan</general><general>Department of Biomedical Safety Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan</general><general>Baishideng Publishing Group Co., Limited</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>2B.</scope><scope>4A8</scope><scope>92I</scope><scope>93N</scope><scope>PSX</scope><scope>TCJ</scope><scope>5PM</scope></search><sort><creationdate>20060407</creationdate><title>Rosuvastatin reduces rat intestinal ischemia-reperfusion injury associated with the preservation of endothelial nitric oxide synthase protein</title><author>Naito, Yuji ; Katada, Kazuhiro ; Takagi, Tomohisa ; Tsuboi, Hisato ; Kuroda, Masaaki ; Handa, Osamu ; Kokura, Satoshi ; Yoshida, Norimasa ; Ichikawa, Hiroshi ; Yoshikawa, Toshikazu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-c66644939aefba29dd2fe212310af0fa6d86daea8adf1e70f475b5793c3a47353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Animals</topic><topic>Basic Research</topic><topic>Chemokine CXCL1</topic><topic>Chemokines, CXC - genetics</topic><topic>Fluorobenzenes - pharmacology</topic><topic>Fluorobenzenes - therapeutic use</topic><topic>Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology</topic><topic>Intestines - blood supply</topic><topic>Lipid Peroxidation - drug effects</topic><topic>Male</topic><topic>Nitric Oxide Synthase Type III - analysis</topic><topic>Pyrimidines - pharmacology</topic><topic>Pyrimidines - therapeutic use</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Reperfusion Injury - enzymology</topic><topic>Reperfusion Injury - prevention &amp; control</topic><topic>RNA, Messenger - analysis</topic><topic>Rosuvastatin Calcium</topic><topic>Sulfonamides - pharmacology</topic><topic>Sulfonamides - therapeutic use</topic><topic>Tumor Necrosis Factor-alpha - genetics</topic><topic>内皮氧化酶</topic><topic>缺血再灌注损伤</topic><topic>肠疾病</topic><topic>蛋白基因</topic><toplevel>online_resources</toplevel><creatorcontrib>Naito, Yuji</creatorcontrib><creatorcontrib>Katada, Kazuhiro</creatorcontrib><creatorcontrib>Takagi, Tomohisa</creatorcontrib><creatorcontrib>Tsuboi, Hisato</creatorcontrib><creatorcontrib>Kuroda, Masaaki</creatorcontrib><creatorcontrib>Handa, Osamu</creatorcontrib><creatorcontrib>Kokura, Satoshi</creatorcontrib><creatorcontrib>Yoshida, Norimasa</creatorcontrib><creatorcontrib>Ichikawa, Hiroshi</creatorcontrib><creatorcontrib>Yoshikawa, Toshikazu</creatorcontrib><collection>中文科技期刊数据库</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Wanfang Data Journals - Hong Kong</collection><collection>WANFANG Data Centre</collection><collection>Wanfang Data Journals</collection><collection>万方数据期刊 - 香港版</collection><collection>China Online Journals (COJ)</collection><collection>China Online Journals (COJ)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of gastroenterology : WJG</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Naito, Yuji</au><au>Katada, Kazuhiro</au><au>Takagi, Tomohisa</au><au>Tsuboi, Hisato</au><au>Kuroda, Masaaki</au><au>Handa, Osamu</au><au>Kokura, Satoshi</au><au>Yoshida, Norimasa</au><au>Ichikawa, Hiroshi</au><au>Yoshikawa, Toshikazu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rosuvastatin reduces rat intestinal ischemia-reperfusion injury associated with the preservation of endothelial nitric oxide synthase protein</atitle><jtitle>World journal of gastroenterology : WJG</jtitle><addtitle>World Journal of Gastroenterology</addtitle><date>2006-04-07</date><risdate>2006</risdate><volume>12</volume><issue>13</issue><spage>2024</spage><epage>2030</epage><pages>2024-2030</pages><issn>1007-9327</issn><eissn>2219-2840</eissn><abstract>AIM: To investigate the protective effect of rosuvastatin on ischemia-reperfusion (I-R)-induced small intestinal injury and inflammation in rats, and to determine the effect of this agent on the expression of endothelial nitric oxide synthase (eNOS) protein. METHODS: Intestinal damage was induced in male Sprague-Dawley rats by clamping both the superior mesenteric artery and the celiac trunk for 30 min, followed by reperfusion for 60 min. Rosuvastatin dissolved in physiological saline was administered intraperitoneally 60 min before ischemia. The severity of the intestinal mucosal injury and inflammation were evaluated by several biochemical markers, as well as by histological findings. The protein levels of eNOS were determined by Western blot. RESULTS: The levels of both intraluminal hemoglobin and protein, as indices of mucosal damage, were significantly increased in the I-R group compared with those in the sham-operated group. These increases, however, were significantly inhibited by treatment with rosuvastatin in a dose-dependent manner. The protective effects of rosuvastatin were also confirmed by histological findings. Exposure of the small intestine to I-R resulted in mucosal inflammation characterized by significant increases in thiobarbituric acid-reactive substances, tissueassociated myeloperoxidase activity, and the mucosal contents of rat cytokine-induced neutrophil chemoattracrant-1 (CINC-1) and tumor necrosis factor-α(TNF-α). These increases in inflammatory parameters after I-R were significantly inhibited by pretreatment with rosuvo astatin at a dose of 10 mg/kg. Furthermore, mRNA expression of CINC-1 and TNF-α was increased after I-R, and this increase was also inhibited by rosuvastatin. The mucosal protein levels of eNOS decreased during I-R, but were preserved in rats treated with rosuvastatin. CONCLUSION: Rosuvastatin inhibits rat intestinal injury and inflammation induced by I-R, and its protection is associated with the preservation of eNOS protein.</abstract><cop>United States</cop><pub>Department of Medical Proteomics, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan%Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine,Kyoto 602-8566, Japan%Department of Biomedical Safety Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan%Molecular Gastroenterology and Hepatology,Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan%Department of Food Sciences and Nutritional Health, The Faculty of Human Environment, Kyoto Prefectural University, Kyoto 606-8522, Japan%Department of Medical Proteomics, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan</pub><pmid>16610051</pmid><doi>10.3748/wjg.v12.i13.2024</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1007-9327
ispartof World journal of gastroenterology : WJG, 2006-04, Vol.12 (13), p.2024-2030
issn 1007-9327
2219-2840
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4087679
source MEDLINE; PubMed Central; Alma/SFX Local Collection
subjects Animals
Basic Research
Chemokine CXCL1
Chemokines, CXC - genetics
Fluorobenzenes - pharmacology
Fluorobenzenes - therapeutic use
Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology
Intestines - blood supply
Lipid Peroxidation - drug effects
Male
Nitric Oxide Synthase Type III - analysis
Pyrimidines - pharmacology
Pyrimidines - therapeutic use
Rats
Rats, Sprague-Dawley
Reperfusion Injury - enzymology
Reperfusion Injury - prevention & control
RNA, Messenger - analysis
Rosuvastatin Calcium
Sulfonamides - pharmacology
Sulfonamides - therapeutic use
Tumor Necrosis Factor-alpha - genetics
内皮氧化酶
缺血再灌注损伤
肠疾病
蛋白基因
title Rosuvastatin reduces rat intestinal ischemia-reperfusion injury associated with the preservation of endothelial nitric oxide synthase protein
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T02%3A09%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wanfang_jour_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rosuvastatin%20reduces%20rat%20intestinal%20ischemia-reperfusion%20injury%20associated%20with%20the%20preservation%20of%20endothelial%20nitric%20oxide%20synthase%20protein&rft.jtitle=World%20journal%20of%20gastroenterology%20:%20WJG&rft.au=Naito,%20Yuji&rft.date=2006-04-07&rft.volume=12&rft.issue=13&rft.spage=2024&rft.epage=2030&rft.pages=2024-2030&rft.issn=1007-9327&rft.eissn=2219-2840&rft_id=info:doi/10.3748/wjg.v12.i13.2024&rft_dat=%3Cwanfang_jour_pubme%3Ewjg200613007%3C/wanfang_jour_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67859244&rft_id=info:pmid/16610051&rft_cqvip_id=21773589&rft_wanfj_id=wjg200613007&rfr_iscdi=true